ROSIGLITAZONE MALEATE AND GLIMEPIRIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rosiglitazone Maleate And Glimepiride, and when can generic versions of Rosiglitazone Maleate And Glimepiride launch?
Rosiglitazone Maleate And Glimepiride is a drug marketed by Teva Pharms Usa and is included in one NDA.
The generic ingredient in ROSIGLITAZONE MALEATE AND GLIMEPIRIDE is glimepiride; rosiglitazone maleate. There are sixteen drug master file entries for this compound. Additional details are available on the glimepiride; rosiglitazone maleate profile page.
Summary for ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ROSIGLITAZONE MALEATE AND GLIMEPIRIDE at DailyMed |
Recent Clinical Trials for ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Canadian Heart Research Centre | Phase 3 |
GlaxoSmithKline | Phase 3 |
See all ROSIGLITAZONE MALEATE AND GLIMEPIRIDE clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
US Patents and Regulatory Information for ROSIGLITAZONE MALEATE AND GLIMEPIRIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms Usa | ROSIGLITAZONE MALEATE AND GLIMEPIRIDE | glimepiride; rosiglitazone maleate | TABLET;ORAL | 078709-001 | Apr 1, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Pharms Usa | ROSIGLITAZONE MALEATE AND GLIMEPIRIDE | glimepiride; rosiglitazone maleate | TABLET;ORAL | 078709-003 | Apr 1, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Pharms Usa | ROSIGLITAZONE MALEATE AND GLIMEPIRIDE | glimepiride; rosiglitazone maleate | TABLET;ORAL | 078709-002 | Apr 1, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |